Reuters: Oramed Says Oral Insulin Succeeds in Midstage Type 2 Diabetes Trial
http://www.reuters.com/article/us-oramed-insulin-idUSKCN0Y91F2
Be Forum: Dancing With Dragons, How a Small Israeli Company Struck a Historic Deal with a Chinese Giant
Josh Hexter, Oramed's COO, spoke with Be Forum and about the company's recent China deal. www.beforum.org/the-bulletin/dancing-with-dragons
BioTuesdays: Oramed sees value creating events through 2016
Josh Hexter, Oramed's COO, spoke with BioTuesdays.com about Oramed's progress and future advances. "Our ORMD-0801 drug candidate has the potential to create a new paradigm in the treatment of diabetes by oral delivery of insulin at an earlier stage of treatment, potentially slowing disease progression and [...]
Seeking Alpha: $50 Million Plus Royalties Deal Indicates Bright Future For Oramed’s Oral Insulin
seekingalpha.com/article/3723676-50-million-plus-royalties-deal-indicates-bright-future-for-orameds-oral-insulin?app=1&auth_param=k8111%3A1b5r8j9%3A005181aa590ef2f22df1979bdbb995c2&uprof=78
In-Pharma: Oramed Inks China Licensing Deal for Oral Insulin Candidate
www.in-pharmatechnologist.com/Drug-Delivery/Oramed-inks-China-licensing-deal-for-oral-insulin-candidate
Times of Israel: Oramed inks huge $50m deal with Chinese pharma firm
www.timesofisrael.com/oramed-inks-huge-50m-deal-with-chinese-pharma-firm/?utm_source=dlvr.it&utm_medium=twitter
Stock News Now (video): Oramed Pharmaceuticals, Inc. – Developing Platform Technology for Oral Delivery of Drugs with Focus on Diabetes
Josh Hexter, Oramed's COO, met with SNNLive at the Aegis Conference in August about Oramed and it's progress http://stocknewsnow.com/commentary/ANEWSID08112015100001/$ORMP-SNNLive-Video-Interview-with-Oramed-Pharmaceuticals
BioPharma Dive: A 21st century diabetes option: Will Oramed be first to market with oral insulin?
Josh Hexter, Oramed's COO, spoke with BioPharma Dive about Oramed's product and progress. “Our oral insulin is not a substitute for insulin injections, but rather a new, earlier treatment option.” http://www.biopharmadive.com/news/a-21st-century-diabetes-option-will-oramed-be-first-to-market-with-oral-in/402100/
Seeking Alpha: Oramed’s Quick Road To Market As Global Leader Of Oral Insulin Capsule
http://seekingalpha.com/instablog/1240561-ray-dirks/4161215-orameds-quick-road-to-market-as-global-leader-of-oral-insulin-capsule
In-Pharma Technologies: Afrezza’s launch a boost for alternate insulin delivery R&D, says Oramed
By: Dan Stanton http://www.in-pharmatechnologist.com/Drug-Delivery/Oramed-Desire-for-alternative-insulin-delivery-shown-with-Afrezza